Cyclo Therapeutics, Inc. (CYTH)
0.7206
0.00 (0.00%)
Inactive · Last trade price
on Mar 26, 2025
Cyclo Therapeutics Employees
Cyclo Therapeutics had 8 employees as of December 31, 2023. The number of employees decreased by 1 or -11.11% compared to the previous year.
Employees
8
Change (1Y)
-1
Growth (1Y)
-11.11%
Revenue / Employee
$108,841
Profits / Employee
-$3,099,959
Market Cap
20.73M
Employees Chart
CYTH News
- 5 weeks ago - CYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc. - CYTH - Business Wire
- 7 weeks ago - Cyclo Therapeutics Presents Positive Preliminary Data from Ongoing Phase 3 TransportNPC™ Open-Label Sub-Study in Patients (< 3 Years Old) - Business Wire
- 2 months ago - Cyclo Therapeutics to Present at the 21st Annual WORLDSymposium™ 2025 - Business Wire
- 3 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LTRPA, LTRPB, CYTH, SKGR on Behalf of Shareholders - PRNewsWire
- 4 months ago - Niemann-Pick Disease Pipeline Market Research 2024: Comprehensive Insights about 12+ Drugs Featuring Cyclo Therapeutics, Azafaros, IntraBio - GlobeNewsWire
- 4 months ago - Cyclo Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - Business Wire
- 7 months ago - Cyclo Therapeutics Presents Encouraging Preliminary Safety Data from Ongoing Pivotal Phase 3 Study and Substudy for the Treatment of Niemann-Pick Disease Type C1 (NPC1) - Business Wire
- 7 months ago - Accession Risk Management Group Closes $1 Billion Financing to Further Accelerate Growth of Risk Strategies and One80 Intermediaries - Business Wire